Skip to main content

Table 1 Correlation between disease severity levels according to the DRSS and ETDRS classification of DR

From: Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy

Disease severity [16]

Findings observable upon dilated ophthalmoscopy [16]

ETDRS level equivalent [16]

Risk assessment [16]

Prevalence of vision-related difficulty [17]

No apparent retinopathy

No abnormalities

Level 10: DR absent

 

Functional burden: 20.2%

Reading: 11.7%

Noticing objects to the side: 4.4%

Mild NPDR

Microaneurysms only

Level 20: Very mild NPDR

 

Functional burden: 20.4%

Reading: 8.5%

Noticing objects to the side: 2.8%

Moderate NPDR

More than just microaneurysms but less than severe NPDR

Levels 35, 43: Mild, moderate NPDR less than 4:2:1

One-year risk for early PDR:

5.4–11.9%

One-year high-risk PDR: 1.2–3.6%

Level 47: Moderately severe NPDR less than 4:2:1

One-year risk for early PDR:

26.3%

One-year high-risk PDR: 8.1%

Severe NPDR

No signs of PR but with any of the following:

 Extensive (> 20) intraretinal hemorrhages in each of the 4 quadrants

 Definite venous beading in ≥ 2 quadrants

 Prominent IRMA in ≥ 1 quadrant

Levels 53A–53E: Severe to very severe NPDR, 4:2:1 rule

One-year risk for early PDR: 50.2% (severe NPDR)

One-year high-risk PDR:

14.6% (severe NPDR)–45.0% (very severe NPDR)

Functional burden: 48.5%

Reading: 33.3%

Noticing objects to the side: 14.5%

PDR

 ≥ 1 of the following:

 Neovascularization

 Vitreous/preretinal hemorrhage

Levels 61, 65, 71, 75, 81, 85: PDR, high-risk PDR, very severe, or advanced PDR

 

Ungradable

 

Level 90: Cannot grade, even sufficiently for level 81 or 85

 
  1. DRSS Diabetic Retinopathy Severity Scale, DR diabetic retinopathy, ETDRS Eary Treatment Diabetic Retinopathy Study, IRMA intraretinal microvascular abnormalities, NPDR non-proliferative diabetic retinopathy, PDR proliferative diabetic retinopathy